BZPEERPapers, people, evidence and research paths
Menu

Discover

SearchFind papers, people, topics, institutions and opportunities from one place.GraphSee how papers, authors, topics and evidence connect.

Research tools

HomeContinue from the papers, people and topics that matter now.CollectionsTurn saved papers into reading lists, evidence maps and shareable context.ResearchReconstruct the path that led you from search to paper to question.CollaborationMove from a paper, topic or expert request into a focused thread.PublishCreate full-text research articles with metadata, formulas and versions.

Network

ExpertsFind specialists whose work and reviews explain why they can help.CommunitiesJoin research groups organized around papers, topics and shared evidence.

Opportunities

ListingsBrowse roles, calls and collaborations connected to real research context.

Account

Log inReturn to your saved papers, graph views and active threads.Create accountStart saving papers, building a research trail and joining teams.
Log inCreate account

Source author record

Alejandro Anderson

Alejandro Anderson appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record
Populations and Evolutionmath.DSmath.OC

Catalog footprint

What is connected

4works
3topics
4close collaborators

Actions

Connect this record

Log in to claim
Open graphBrowse works

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

4 published item(s)

preprint2025arXiv

Failure and Success in Single-Drug Control of Antimicrobial Resistance

We propose a mathematical model of Antimicrobial Resistance in the host to predict the failure of two antagonists of bacterial growth: the immune response and a single-antibiotic therapy. After characterising the initial bacterial load that cannot be cleared by the immune system alone, we define the success set of initial conditions for which an infection-free equilibrium can be reached by a viable single-antibiotic therapy, and we provide a rigorously defined inner approximation of the set. For initial conditions within the success set, we propose an optimal control framework to design single-drug therapies.

0 citations0 reviewsNo code linkedOpen access
preprint2020arXiv

Characterization of SARS-CoV-2 Dynamics in the Host

While many epidemiological models have being proposed to understand and handle COVID-19, too little has been invested to understand how the virus replicates in the human body and potential antiviral can be used to control the replication cycle. In this work, using a control theoretical approach, validated mathematical models of SARS-CoV-2 in humans are properly characterized. A complete analysis of the main dynamic characteristic is developed based on the reproduction number. The equilibrium regions of the system are fully characterized, and the stability of such a regions, formally established. Mathematical analysis highlights critical conditions to decrease monotonically SARS-CoV-2 in the host, such conditions are relevant to tailor future antiviral treatments. Simulation results show the potential benefits of the aforementioned system characterization.

0 citations0 reviewsNo code linkedOpen access
preprint2020arXiv

Discrete-time MPC for switched systems with applications to biomedical problems

Switched systems in which the manipulated control action is the time-depending switching signal describe many engineering problems, mainly related to biomedical applications. In such a context, to control the system means to select an autonomous system - at each time step - among a given finite family. Even when this selection can be done by solving a Dynamic Programming (DP) problem, such a solution is often difficult to apply, and state/control constraints cannot be explicitly considered. In this work a new set-based Model Predictive Control (MPC) strategy is proposed to handle switched systems in a tractable form. The optimization problem at the core of the MPC formulation consists in an easy-to-solve mixed-integer optimization problem, whose solution is applied in a receding horizon way. Two biomedical applications are simulated to test the controller: (i) the drug schedule to attenuate the effect of viral mutation and drugs resistance on the viral load, and (ii) the drug schedule for Triple Negative breast cancer treatment. The numerical results suggest that the proposed strategy outperform the schedule for available treatments.

0 citations0 reviewsNo code linkedOpen access
preprint2020arXiv

Dynamical Characterization of Antiviral Effects in COVID-19

Mathematical models describing SARS-CoV-2 dynamics and the corresponding immune responses in patients with COVID-19 can be critical to evaluate possible clinical outcomes of antiviral treatments. In this work, based on the concept of virus spreadability in the host, antiviral effectiveness thresholds are determined to establish whether or not a treatment will be able to clear the infection. In addition, the virus dynamic in the host -- including the time-to-peak and the final monotonically decreasing behavior -- is chracterized as a function of the treatment initial time. Simulation results, based on nine real patient data, show the potential clinical benefits of a treatment classification according to patient critical parameters. This study is aimed at paving the way for the different antivirals being developed to tackle SARS-CoV-2.

0 citations0 reviewsNo code linkedOpen access